Sign in

or Register now

MyBreastCancerNetwork.com

See all of our health sites at www.HealthCentral.com
Sunday, October, 25, 2009

Evista

Evista approved for breast cancer

October 03, 2008
The Food and Drug Administration has approved the osteoporosis med Evista for use in reducing the risk of breast cancer. Evista is approved to treat postmenopausal women who are at high risk of invasive breast cancer, the drugmaker says. Read more »

Expert & Community Posts

9487_4775
Evista vs. Breast Cancer?
By Lila de Tantillo , Health Expert

...intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its... Read more »

73_5766
Evista (Raloxifene), Breast Cancer and Osteoporosis
By Neil Gonter, MD , Health Expert

...make changes in their treatment of osteoporosis.   Evista is commonly referred to as a... Read more »

78
Evista FAQs - Hormone Therapy for Breast Cancer
By PJ Hamel , Health Expert

...osteoporosis, too. My doctor has recommended I take Evista, which she said would help on both... Read more »

9847_8670
Evista, New Breast Cancer Treatment
By Lila de Tantillo , Health Expert

...after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »

9487_4775
Update on Evista and Kidney Disease
By Lila de Tantillo , Health Expert

...indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating... Read more »

Health Guide

Breast Cancer Information and Types of Breast Cancer
Tamoxifen and Raloxifene for PreventionRaloxifene (Evista) works as well as tamoxifen (Nolvadex) in reducing the risk of invasive breast cancer in women with BRCA gene mutations, indicates... Read more »
Uterine Fibroids and Hysterectomy: Medications
...hormone teriparatide (Forteo) and selective estrogen-receptor modulators (SERMs), such as raloxifene (Evista).GnRH treatments used alone do not prevent pregnancy. Furthermore, if a woman becomes... Read more »
Endometriosis: Medications
...hormone teriparatide (Forteo) and selective estrogen-receptor modulators (SERMs), such as raloxifene (Evista).GnRH treatments used alone do not prevent pregnancy. Furthermore, if a woman becomes... Read more »
Osteoporosis: Medications
...dentist if you experience any jaw or gum discomfort while taking a bisphosphonate drug.SERMsRaloxifene (Evista) belongs to a class of drugs called selective estrogen-receptor modulators (SERMs).... Read more »
Breast Cancer: Lifestyle Changes
...cancers. However, it has no protective effects against estrogen receptor-negative cancers.Raloxifene (Evista), another SERM, also protects against breast cancer and osteoporosis and has a lower... Read more »

Medications

Lly41650_95511_5

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »

Lly41650_95511_5

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »

Lly41650_95511_5

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »

Lly41650_95511_5

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »

Lly41650_95511_5

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause.... Read more »

Related News

Clinical trial: Arzoxifene vs. Evista in women with osteoporosis
October 03, 2008

This is a study to compare the effects of arzoxifene to Evista on bone mineral density in women with osteoporosis. This international study is... Read summary »

FDA panel recommends Evista to cut breast cancer risk
October 03, 2008

A Food and Drug Administration (FDA) panel has recommended Evista for use in preventing breast cancer. Evista is an osteoporosis medication that has... Read summary »

Clinical trial: Evista for women with Alzheimer's
October 03, 2008

This is a study to determine whether the osteoporosis med Evista improves cognitive function in women with Alzheimer's disease. This national study... Read summary »

Clinical trial: Zometa and Evista's effects on bone mineral density
October 03, 2008

This is a study to compare the effects of Zometa and Evista in reducing bone turnover markers in postmenopausal women who have low bone mineral... Read summary »

Generic Evista gets tentative OK
October 03, 2008

The U.S. Food and Drug Administration has granted tentative approval for a generic form of the commonly used osteoporosis drug Evista. However, the... Read summary »